| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cost of revenue | - | - | 13,748 | 14,826 |
| Total revenues | 82,130 | 76,527 | 78,354 | 70,079 |
| General and administrative expense, total | - | - | - | 10,823 |
| Cost of goods sold - commercial | 4,498 | 4,607 | 3,768 | 3,197 |
| Selling expense | - | - | - | 13,093 |
| Cost of revenue-License And Service | 15,705 | 15,961 | - | - |
| Research and development | 14,063 | 13,675 | 11,022 | 12,926 |
| Selling, general and administrative | 29,088 | 31,622 | 25,014 | - |
| (gain) loss on foreign currency transaction | 120 | -5,363 | -2,509 | -2,454 |
| Total expenses | 63,234 | 71,228 | 56,061 | 57,319 |
| Income from operations | 18,896 | 5,299 | 22,293 | 12,760 |
| Other income | - | - | - | 32 |
| Interest income, net | 2,628 | 1,832 | 1,956 | 3,179 |
| Gain on bargain purchase | - | - | - | 5,259 |
| Interest expense | 1,364 | 285 | 4,645 | 1,801 |
| Interest expense on liability for sale of future royalties | 3,514 | 3,473 | 3,577 | 4,089 |
| Interest expense on financing liability | 2,456 | 2,433 | 2,410 | 2,470 |
| Impairment of available-for-sale investment | 6,409 | - | - | - |
| Total other (expense) income | -11,115 | -4,359 | -8,676 | 110 |
| Income before income tax (benefit) expense | 7,781 | 940 | 13,617 | 12,870 |
| Income tax (benefit) provision | -204 | 272 | 459 | 1,320 |
| Net income | 7,985 | 668 | 13,158 | 11,550 |
| Earnings per share basic | 0.03 | 0 | 0.04 | 0.04 |
| Earnings per share diluted | 0.03 | 0 | 0.04 | 0.04 |
| Weighted average common shares (denominator), basic | 306,806,000 | 304,954,000 | 303,481,000 | 274,998,000 |
| Weighted average number of diluted shares outstanding | 311,638,000 | 311,484,000 | 320,897,000 | 284,693,000 |
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)